Crinetics Pharmaceuticals Inc (CRNX)
48.75
-0.67
(-1.36%)
USD |
NASDAQ |
Jan 08, 12:35
Crinetics Pharmaceuticals SG&A Expense (Quarterly): 25.89M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Clearside Biomedical Inc | 2.844M |
| Biomea Fusion Inc | 6.795M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |
| iBio Inc | 2.801M |